Exercise and nutrition program for muscle preservation during GLP-1 treatment
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 40 and 55 years old
- BMI greater than 30 (considered obese) with elevated body fat percentage
- Currently eligible to start or already taking GLP-1 medication
- No diagnosis of type 2 diabetes
- Able to safely participate in moderate exercise without dangerous changes in heart rate or blood pressure
- No significant musculoskeletal problems (joint, bone, or muscle pain) that would prevent exercise participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special medical food to help keep muscle mass while losing weight with GLP-1 medications like liraglutide, semaglutide, or tirzepatide. It's for adults with obesity or overweight with related health issues.
This trial tests a new medicine, (S)-pindolol benzoate, given along with semaglutide (Ozempic/Wegovy). The goal is to see if it helps people lose mostly fat instead of muscle while on a weight loss program.
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
This study looks at whether a guided strength-training app can help women in their 40s and 50s who are starting a GLP-1 medication (like Ozempic or Wegovy) build muscle and stay healthy. You'd follow a home-based workout plan for 12 weeks and attend a few in-person visits.
This study tests a 6-month behavioral program (including exercise, diet, and mindfulness) designed to help you keep weight off after stopping GLP-1 or similar weight-loss medications. It's for people who have already lost at least 15% of their body weight and stopped or are stopping these medications.
This trial looks at how GLP-1 receptor agonist medications (like liraglutide or semaglutide) affect bone health in adolescents and young adults with obesity. It aims to understand if these weight loss drugs have any impact on bone density and metabolism.
Hear when a new GLP-1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.